Loading clinical trials...
Loading clinical trials...
The Efficacy of Preoperative Oral Administration of Lactobacillus Reuteri Combined With Preoperative Neoadjuvant/Conversion Immunotherapy in Patients With Primary Resectable Liver Cancer: a Prospective Study
Conditions
Interventions
Dietary Supplement: L. reuteri DSM 17938
Start Date
December 20, 2025
Primary Completion Date
June 20, 2028
Completion Date
December 20, 2028
Last Updated
December 29, 2025
NCT07285850
NCT07106827
NCT06999837
NCT07141056
NCT07132515
NCT06999707
Lead Sponsor
Fujian Cancer Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions